Physician profile
Ivan J Antosh
NPI 1902960545
$9,580.61
in general payments reported to CMS, 2019-2025
13 companies · $531 in 2025
The $531 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,623 · 2020: $1,810 · 2021: $1,317 · 2022: $39.31 · 2023: $353 · 2024: $906 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,103 · Travel and Lodging: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.56 |
| Travel and Lodging | $688.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $5,727.44 | 2019-2023 | |
| Zimmer Biomet Holdings, INC. | $1,059.23 | 2019 | |
| Encore Medical, LP | $729.37 | 2023-2024 | Djo Surgical |
| Stryker Corporation | $545.94 | 2021-2025 | Secur-Fit, Biolox, Accolade |
| Arthrex, INC. | $367.00 | 2021 | |
| Exactech, INC. | $284.66 | 2023 | |
| Mission Medical Distribution, LLC | $257.55 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $181.58 | 2019-2025 | Exparel |
| Vericel Corporation | $164.84 | 2019-2022 | |
| Medtronic, INC. | $117.11 | 2025 | Inceptiv |
| Bioventus LLC | $98.00 | 2019 | |
| Osteoremedies, LLC | $31.25 | 2019 | |
| Smith+Nephew, INC. | $16.64 | 2025 | Synergy, Evos, Trigen Intertan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivan Antosh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.